These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27402891)

  • 1. Development and validation of the Myasthenia Gravis Impairment Index.
    Barnett C; Bril V; Kapral M; Kulkarni A; Davis AM
    Neurology; 2016 Aug; 87(9):879-86. PubMed ID: 27402891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Italian version of the Myasthenia Gravis Impairment Index (MGII).
    Pasqualin F; Barnett C; Guidoni SV; Albertini E; Ermani M; Bonifati DM
    Neurol Sci; 2022 Mar; 43(3):2059-2064. PubMed ID: 34505205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia Gravis Impairment Index: Responsiveness, meaningful change, and relative efficiency.
    Barnett C; Bril V; Kapral M; Kulkarni AV; Davis AM
    Neurology; 2017 Dec; 89(23):2357-2364. PubMed ID: 29101274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation and validation of the 15-item Myasthenia Gravis Quality of life scale in Dutch.
    Strijbos E; Gärtner FR; Verschuuren JJ
    Muscle Nerve; 2018 Feb; 57(2):206-211. PubMed ID: 28271514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia Gravis Impairment Index: Sensitivity for Change in Generalized Muscle Weakness.
    de Meel RHP; Barnett C; Bril V; Tannemaat MR; Verschuuren JJGM
    J Neuromuscul Dis; 2020; 7(3):297-300. PubMed ID: 32250313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reliability study of impairment and disability scales for myasthenia gravis patients.
    Romani A; Piccolo G; Bergamaschi R; Versino M; Cosi V
    Funct Neurol; 2002; 17(3):137-44. PubMed ID: 12549719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity, reliability, and sensitivity to change of the myasthenia gravis activities of daily living profile in a sample of Italian myasthenic patients.
    Raggi A; Antozzi C; Baggi F; Leonardi M; Maggi L; Mantegazza R
    Neurol Sci; 2017 Nov; 38(11):1927-1931. PubMed ID: 28780706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-acceptable symptom states in myasthenia gravis.
    Mendoza M; Tran C; Bril V; Katzberg HD; Barnett C
    Neurology; 2020 Sep; 95(12):e1617-e1628. PubMed ID: 32759200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation and validation of the arabic version of the revised 15-item myasthenia gravis quality-of-life questionnaire.
    Alanazy MH; Abuzinadah AR; Muayqil T
    Muscle Nerve; 2018 Apr; 57(4):581-585. PubMed ID: 28857210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and reliability of the Polish version of myasthenia gravis - Quality of life questionnaire - 15 item.
    Rozmilowska I; Adamczyk-Sowa M; Pierzchala K; Czyzewski D
    Neurol Neurochir Pol; 2017; 51(4):311-318. PubMed ID: 28579082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of a single simple question in the evaluation of patients with myasthenia gravis.
    Abraham A; Breiner A; Barnett C; Katzberg HD; Bril V
    Muscle Nerve; 2018 Feb; 57(2):240-244. PubMed ID: 28590545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the italian version of the 15-item Myasthenia Gravis Quality-of-Life questionnaire.
    Raggi A; Leonardi M; Ayadi R; Antozzi C; Maggi L; Baggi F; Mantegazza R
    Muscle Nerve; 2017 Oct; 56(4):716-720. PubMed ID: 28029697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the 15-item myasthenia gravis quality of life questionnaire (MG-QOL15) Persian version.
    Ostovan VR; Fatehi F; Davoudi F; Nafissi S
    Muscle Nerve; 2016 Jun; 54(1):65-70. PubMed ID: 26661455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MG Composite: A valid and reliable outcome measure for myasthenia gravis.
    Burns TM; Conaway M; Sanders DB;
    Neurology; 2010 May; 74(18):1434-40. PubMed ID: 20439845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional exercise capacity evaluated by timed walk tests in myasthenia gravis.
    Salci Y; Karanfil E; Balkan AF; Kütükçü EÇ; Ceren AN; Ayvat F; Bekircan-Kurt CE; Armutlu K
    Muscle Nerve; 2019 Feb; 59(2):208-212. PubMed ID: 30230561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and Validity of Turkish Myasthenia Gravis-Activities of Daily Living Scale.
    Karanfil E; Salcı Y; Fil-Balkan A; Bekircan-Kurt CE; Erdem Özdamar S; Armutlu K
    OTJR (Thorofare N J); 2021 Apr; 41(2):101-107. PubMed ID: 33016212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation and validation of the arabic version of the myasthenia gravis activities of daily living scale.
    Alanazy MH; Abuzinadah AR; Muayqil T
    Muscle Nerve; 2019 May; 59(5):583-586. PubMed ID: 30697753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translation, cross-cultural adaptation, and validation of the french version of the 15-item Myasthenia Gravis Quality Of life scale.
    Birnbaum S; Ghout I; Demeret S; Bolgert F; Eymard B; Sharshar T; Portero P; Hogrel JY
    Muscle Nerve; 2017 May; 55(5):639-645. PubMed ID: 27533497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index.
    Salaffi F; Stancati A; Neri R; Grassi W; Bombardieri S
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S31-42. PubMed ID: 16273783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of the scale for symptom clusters in patients with myasthenia gravis.
    Shen F; Hu LH; Huang HS; Li L
    BMC Neurol; 2023 May; 23(1):196. PubMed ID: 37208623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.